These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3719471)

  • 41. Millipore analysis of valvular fluid in sterile valve malfunctions.
    Traynelis VC; Willison CD; Follett KA; Chambers J; Schochet SS; Kaufman HH
    Neurosurgery; 1991 Jun; 28(6):848-52. PubMed ID: 2067607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pudenz antisiphon device tear as a cause of shunt malfunction.
    Borowitz B; Ashkenazi E; Muallem N; Constantini S
    Childs Nerv Syst; 1989 Oct; 5(5):330-1. PubMed ID: 2805005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determining the best cerebrospinal fluid shunt valve design: the pediatric valve design trial.
    Drake JM; Kestle J
    Neurosurgery; 1996 Mar; 38(3):604-7. PubMed ID: 8837819
    [No Abstract]   [Full Text] [Related]  

  • 44. Complications of endoscopic third ventriculostomy in previously shunted patients.
    Hader WJ; Walker RL; Myles ST; Hamilton M
    Neurosurgery; 2008 Jul; 63(1 Suppl 1):ONS168-74; discussion ONS174-5. PubMed ID: 18728596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Shunting operation with the medos programmable valve shunt system].
    Izumihara A; Orita T; Tsurutani T; Kajiwara K
    No Shinkei Geka; 1994 Aug; 22(8):731-5. PubMed ID: 8072630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts.
    Borgbjerg BM; Gjerris F; Albeck MJ; Børgesen SE
    Acta Neurochir (Wien); 1995; 136(1-2):1-7. PubMed ID: 8748819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disconnection as a cause of ventriculoperitoneal shunt malfunction in multicomponent shunt systems.
    Aldrich EF; Harmann P
    Pediatr Neurosurg; 1990-1991; 16(6):309-11; discussion 312. PubMed ID: 2134742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CSF shunt complications: an analysis of contributory factors.
    Griebel R; Khan M; Tan L
    Childs Nerv Syst; 1985; 1(2):77-80. PubMed ID: 4005887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The complementary role of plain radiographs and radionuclide shuntography in evaluating CSF-VP shunts.
    Blair K; AuCoin R; Kloiber R; Molnar CP
    Clin Nucl Med; 1989 Feb; 14(2):121-3. PubMed ID: 2731390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Function of parietal and frontal shunts in childhood hydrocephalus.
    Albright AL; Haines SJ; Taylor FH
    J Neurosurg; 1988 Dec; 69(6):883-6. PubMed ID: 3193193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebrospinal fluid edema: a rare complication of shunt operations for hydrocephalus. Report of three cases.
    Chiba Y; Takagi H; Nakajima F; Fujii S; Kitahara T; Yagishita S; Itoh Y
    J Neurosurg; 1982 Nov; 57(5):697-700. PubMed ID: 7131072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical outcome of cerebrospinal fluid shunts in patients with leptomeningeal carcinomatosis.
    Kim HS; Park JB; Gwak HS; Kwon JW; Shin SH; Yoo H
    World J Surg Oncol; 2019 Mar; 17(1):59. PubMed ID: 30917830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002.
    Curry WT; Butler WE; Barker FG
    Neurosurgery; 2005 Jul; 57(1):97-108; discussion 97-108. PubMed ID: 15987545
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Medos Hakim programmable valve in the treatment of pediatric hydrocephalus.
    Reinprecht A; Dietrich W; Bertalanffy A; Czech T
    Childs Nerv Syst; 1997; 13(11-12):588-93; discussion 593-4. PubMed ID: 9454974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A search for determinants of cerebrospinal fluid shunt survival: retrospective analysis of a 14-year institutional experience.
    Piatt JH; Carlson CV
    Pediatr Neurosurg; 1993; 19(5):233-41; discussion 242. PubMed ID: 8398847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What is the risk of a shunt malfunction after elective intradural surgery?
    Venable GT; Green CS; Smalley ZS; Bedford EC; Modica JS; Klimo P
    J Neurosurg Pediatr; 2015 Dec; 16(6):642-7. PubMed ID: 26359674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors influencing spinal canal stenosis in patients with long-term controlled hydrocephalus treated with cerebrospinal fluid shunt.
    Nomura S; Fujii M; Kajiwara K; Ishihara H; Suehiro E; Goto H; Suzuki M
    Childs Nerv Syst; 2010 Jul; 26(7):931-5. PubMed ID: 20157714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus.
    Govender ST; Nathoo N; van Dellen JR
    J Neurosurg; 2003 Nov; 99(5):831-9. PubMed ID: 14609161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Subdural hematoma as a complication of shunting procedures for hydrocephalus (author's transl)].
    Suematsu K; Tsuchida H; Sohma T; Kanwo K
    No Shinkei Geka; 1977 Nov; 5(12):1261-6. PubMed ID: 593517
    [No Abstract]   [Full Text] [Related]  

  • 60. [A rare complication of the shunt operation in hydrocephalus. Extension of the cerebrospinal fluid into the cerebral parenchyma along the ventricular catheter (author's transl)].
    Chiba Y; Takagi H; Nakajima F; Fujii S; Kitahara T; Yagishita S; Ito Y
    Neurol Med Chir (Tokyo); 1982 May; 22(5):378-82. PubMed ID: 6180339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.